N
2.41
0.04 (1.69%)
| Previous Close | 2.37 |
| Open | 2.51 |
| Volume | 42,839 |
| Avg. Volume (3M) | 44,653 |
| Market Cap | 18,446,238 |
| Price / Earnings (Forward) | 44.25 |
| Price / Sales | 1.99 |
| Price / Book | 3.54 |
| 52 Weeks Range | |
| Earnings Date | 13 May 2025 |
| Profit Margin | -37.76% |
| Operating Margin (TTM) | -27.65% |
| Diluted EPS (TTM) | -0.500 |
| Quarterly Revenue Growth (YOY) | 181.10% |
| Total Debt/Equity (MRQ) | 46.48% |
| Current Ratio (MRQ) | 2.07 |
| Operating Cash Flow (TTM) | -3.87 M |
| Levered Free Cash Flow (TTM) | -2.74 M |
| Return on Assets (TTM) | -21.22% |
| Return on Equity (TTM) | -61.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | NexGel, Inc | Mixed | Mixed |
AIStockmoo Score
-0.7
| Analyst Consensus | -2.0 |
| Insider Activity | -1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.70 |
|
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 17.21% |
| % Held by Institutions | 6.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Simon Quick Advisors, Llc | 31 Dec 2024 | 35,715 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HENRY SCOTT ROBERT | - | 2.72 | -3,000 | -8,160 |
| Aggregate Net Quantity | -3,000 | |||
| Aggregate Net Value ($) | -8,160 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 2.72 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HENRY SCOTT ROBERT | Director | 12 May 2025 | Automatic sell (-) | 3,000 | 2.72 | 8,160 |
| Date | Type | Details |
|---|---|---|
| 21 May 2025 | Announcement | NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd |
| 13 May 2025 | Announcement | NEXGEL Reports First Quarter 2025 Financial Results |
| 09 May 2025 | Announcement | NEXGEL to Report First Quarter 2025 Financial Results on May 13th |
| 07 Apr 2025 | Announcement | NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th |
| 24 Mar 2025 | Announcement | NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results |
| 21 Mar 2025 | Announcement | iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 |
| 19 Mar 2025 | Announcement | NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |